The chairman of the Department of Genetic Medicine at Weill Cornell Medicine detailed the ongoing research in developing gene therapy for patients with Alzheimer disease.
Ronald Crystal, MD
Advertisement
Articles by Ronald Crystal, MD
The chairman of the Department of Genetic Medicine at Weill Cornell Medicine detailed the ongoing research in developing gene therapy for patients with Alzheimer disease.
Could the introduction of gene therapies into the Alzheimer space be the beginning of a new era of treatment?
The chairman of the Department of Genetic Medicine at Weill Cornell Medicine shared his experience with the therapy and its potential in the space.
Advertisement
Latest Updated Articles
Ronald Crystal, MD: APOE2 Gene Therapy for Alzheimer DiseasePublished: September 17th 2018 | Updated:
Ronald Crystal, MD: Introducing Genetics into Alzheimer DiseasePublished: September 18th 2018 | Updated:
Ronald Crystal, MD: Developing Gene Therapy in Alzheimer DiseasePublished: October 17th 2020 | Updated:
- Ronald Crystal, MD: The Possibilities of Gene Therapy in Neurodegenerative Disease
Published: October 19th 2020 | Updated:
